Samuele Ferrari

1.6k total citations · 1 hit paper
20 papers, 746 citations indexed

About

Samuele Ferrari is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Samuele Ferrari has authored 20 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Genetics and 7 papers in Oncology. Recurrent topics in Samuele Ferrari's work include Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (14 papers) and CAR-T cell therapy research (6 papers). Samuele Ferrari is often cited by papers focused on Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (14 papers) and CAR-T cell therapy research (6 papers). Samuele Ferrari collaborates with scholars based in Italy, United States and Spain. Samuele Ferrari's co-authors include Luigi Naldini, Luisa Albano, Aurélien Jacob, Pietro Genovese, Valentina Vavassori, Ivan Merelli, Stefano Beretta, Chiara Brombin, Giulia Schiroli and Daniele Canarutto and has published in prestigious journals such as Science, Cell and SHILAP Revista de lepidopterología.

In The Last Decade

Samuele Ferrari

19 papers receiving 738 citations

Hit Papers

Genotoxic effects of base and prime editing in human hema... 2023 2026 2024 2025 2023 25 50 75

Peers

Samuele Ferrari
Giulia Schiroli United States
Carmencita E. Nicolas United States
Alexander Astrakhan United States
Nikoletta Psatha United States
Alec B. Wilkens United States
Beruh Dejene United States
Fabrizia Urbinati United States
Samuele Ferrari
Citations per year, relative to Samuele Ferrari Samuele Ferrari (= 1×) peers Aurélien Jacob

Countries citing papers authored by Samuele Ferrari

Since Specialization
Citations

This map shows the geographic impact of Samuele Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuele Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuele Ferrari more than expected).

Fields of papers citing papers by Samuele Ferrari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuele Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuele Ferrari. The network helps show where Samuele Ferrari may publish in the future.

Co-authorship network of co-authors of Samuele Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Samuele Ferrari. A scholar is included among the top collaborators of Samuele Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuele Ferrari. Samuele Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomelleri, Alessandro, Samuele Ferrari, Marco Matucci‐Cerinic, et al.. (2025). Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome. Expert Review of Hematology. 18(7). 509–519. 1 indexed citations
2.
Beretta, Stefano, Laura Passerini, Marilena Mancino, et al.. (2024). Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(8). 119818–119818. 1 indexed citations
3.
Asperti, Claudia, Daniele Canarutto, Simona Porcellini, et al.. (2023). Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo. Molecular Therapy — Methods & Clinical Development. 30. 546–557. 3 indexed citations
4.
Canarutto, Daniele, Claudia Asperti, Valentina Vavassori, et al.. (2023). Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4 + T‐cells for the treatment of Hyper IgM1. The EMBO Journal. 42(23). e114188–e114188. 5 indexed citations
5.
Ferrari, Samuele, Attya Omer, Stefano Beretta, et al.. (2023). Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nature Biotechnology. 42(6). 877–891. 93 indexed citations breakdown →
6.
Vavassori, Valentina, Samuele Ferrari, Stefano Beretta, et al.. (2023). Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells. Blood. 142(9). 812–826. 40 indexed citations
7.
Canarutto, Daniele, et al.. (2023). Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation. British Medical Bulletin. 147(1). 108–120. 7 indexed citations
8.
Castiello, Maria Carmina, Samuele Ferrari, & Anna Villa. (2023). Correcting inborn errors of immunity: From viral mediated gene addition to gene editing. Seminars in Immunology. 66. 101731–101731. 8 indexed citations
9.
Ferrari, Samuele, Anastasia Conti, Serena Scala, et al.. (2023). Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell stem cell. 30(5). 549–570. 26 indexed citations
10.
Ferrari, Samuele, Attya Omer, Stefano Beretta, et al.. (2023). P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS. HemaSphere. 7(S3). e6237653–e6237653. 1 indexed citations
11.
Conti, Anastasia, Rosaria De Marco, Samuele Ferrari, et al.. (2023). S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR-CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS. HemaSphere. 7(S3). e7928137–e7928137.
12.
Ferrari, Samuele & Luigi Naldini. (2023). A step toward stem cell engineering in vivo. Science. 381(6656). 378–379. 2 indexed citations
13.
Crippa, Stefania, Anastasia Conti, Valentina Vavassori, et al.. (2022). Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. Molecular Therapy. 31(1). 230–248. 10 indexed citations
14.
Omer, Attya, Luisa Albano, Claire Latroche, et al.. (2022). Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells. Cell. 185(13). 2248–2264.e21. 36 indexed citations
15.
Ferrari, Samuele, Stefano Beretta, Aurélien Jacob, et al.. (2021). BAR-Seq clonal tracking of gene-edited cells. Nature Protocols. 16(6). 2991–3025. 9 indexed citations
16.
Ferrari, Samuele, Valentina Vavassori, Daniele Canarutto, et al.. (2021). Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation. SHILAP Revista de lepidopterología. 3. 618378–618378. 30 indexed citations
17.
Ferrari, Samuele, Aurélien Jacob, Stefano Beretta, et al.. (2020). Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nature Biotechnology. 38(11). 1298–1308. 108 indexed citations
18.
Schiroli, Giulia, Anastasia Conti, Samuele Ferrari, et al.. (2019). Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell stem cell. 24(4). 551–565.e8. 203 indexed citations
19.
Schiroli, Giulia, Samuele Ferrari, Anthony Conway, et al.. (2017). Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Science Translational Medicine. 9(411). 159 indexed citations
20.
Parodi, Monica, et al.. (1991). Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).. PubMed. 11(2). 947–52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026